FIRM FIXED PRICE
OPTUM PHARMACY 801, INC. - CONTINGENCY HAZARDOUS PHARMACEUTICAL COMPOUNDING - RENO
PIID: 36C26125N0076
Signed Date: Nov 3, 2025Effective Date: Oct 1, 2024End Date: Closed on Sep 30, 2025
Key Details
Description
CONTINGENCY HAZARDOUS PHARMACEUTICAL COMPOUNDING - RENO
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.
Related
Agencies
Vendors